Physicians and cytologists need the most up-todate knowledge and strategies in pathology and cytopathology in order to provide the most appropriate ancillary testing for their patients, and for guiding patient management. With the current update, attendees will learn the various new evidence-based reporting terminologies or updates to previously existing ones. This will enable them to assess the patient’s risk of malignancy specifically regarding findings in thyroid, respiratory, urinary, body fluid, salivary and pancreatobiliary cytology and small biopsies. By understanding
these new site-specific reporting systems, attendees will know the risk of malignancy associated with each reporting category and appropriate ancillary testing; and therefore better guide management of their patients.
The World Health Organization, under the guidance of the International Academy of Cytology and other organizations, is currently in the process of publishing cytopathology reporting terminology. An update/status on these will be provided. Additionally, digital pathology and other new technologies — as they apply specifically to cytology and small specimens — will be discussed. New developments in the field that will impact patient care in the future will also be presented.
Saturday, February 18 at 8:00am to 5:15pm
Houston Methodist Research Institute, Bookout Auditorium - 2nd Floor
6670 Bertner Avenue